This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Importance of 2-Antiplasmin in the Defibrination Syndrome

PAUL L. WOLF, MD

Arch Intern Med. 1989;149(8):1724-1725.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Two coagulation abnormalities may result in a marked decrease in plasma fibrinogen caused by prominent defibrination. The two conditions that cause defibrination with a bleeding diathesis are disseminated intravascular coagulation (DIC) and primary fibrinogenolysis (PF).¹

Various conditions may be associated with DIC. These include serious infections; complications of pregnancy, such as abruptio placentae or toxemia (PIH); malignancy, such as carcinomas or acute promyelocytic leukemia; marked tissue injury, such as brain injury and incompatible hemolytic transfusion reaction; and venomous snakebite.

The cause of PF differs from DIC. Primary fibrinogenolysis is associated with cirrhosis, since the liver normally removes plasminogen activator from the circulation. Other conditions associated with PF are extensive cardiovascular or pulmonary surgery and metastatic carcinoma of the prostate, releasing plasminogen activator into the circulation. The recent utilization of tissue plasminogen activator to cause thrombolysis of coronary artery and cerebral artery thrombi causes local fibrinogenolysis.

The laboratory parameters used . . . [Full Text PDF of this Article]

Author Affiliations
Department of Pathology and Laboratory Medicine University of California at San Diego Medical Center 225 Dickinson St San Diego, CA 92103

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?